Investigating the mechanism(s) associated with impaired tumor immunogenicity in a mouse model of breast cancer

研究乳腺癌小鼠模型中肿瘤免疫原性受损的相关机制

• 批准号: 486132
• 负责人: Rahmati Amirhossein
• 金额: $ 1.27万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-12-01 至 2023-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486132&lang=en
• 关键词: Breast Cancer; Cd71+ Erythroid Precursors; Immune Suppression; Immune System; Immunology; Metastasis; Red Blood Cell Precursors; T Cells; Tumor Microenvironment; Tumor Progression

Breast cancer is the primary cause of cancer death in women worldwide, accounting for 25% of the total cancer cases and 15% of cancer-related mortality in women. Additionally, the incidence of breast cancer in North America is on the rise. Cancer metastas

乳腺癌是全世界妇女癌症死亡的主要原因，占癌症病例总数的25%，占妇女癌症相关死亡率的15%。此外，乳腺癌在北美的发病率正在上升。癌症metastas